AAAAAA
Results: 1-25/73
Authors:
LAFONTAN M
BRESSON JL
VAGUE P
Citation: M. Lafontan et al., RECOMMENDATIONS FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF OBESITY, DIABETES & METABOLISM, 24, 1998, pp. 1-1
Authors:
RACCAH D
COSTE T
CAMERON NE
DUFAYET D
VAGUE P
HOHMAN TC
Citation: D. Raccah et al., EFFECT OF THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT ON NERVE-CONDUCTION VELOCITY NA K ATPASE ACTIVITY, AND POLYOLS IN RED-BLOOD-CELLS, SCIATIC-NERVE, KIDNEY CORTEX, AND KIDNEY MEDULLA OF DIABETIC RATS/, Journal of diabetes and its complications, 12(3), 1998, pp. 154-162
Authors:
JANANDDELENNE B
CHAGNAUD C
RACCAH D
ALESSI MC
JUHANVAGUE I
VAGUE P
Citation: B. Jananddelenne et al., VISCERAL FAT AS A MAIN DETERMINANT OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVEL IN WOMEN, International journal of obesity, 22(4), 1998, pp. 312-317
Authors:
CHARLES MA
MORANGE P
ESCHWEGE E
ANDRE P
VAGUE P
JUHANVAGUE I
Citation: Ma. Charles et al., EFFECT OF WEIGHT CHANGE AND METFORMIN ON FIBRINOLYSIS AND THE VON-WILLEBRAND-FACTOR IN OBESE NONDIABETIC SUBJECTS - THE BIGPRO1 STUDY, Diabetes care, 21(11), 1998, pp. 1967-1972
Authors:
LASSMANNVAGUE V
SANMARCO M
LEJEUNE PJ
ALESSIS C
VAGUE P
BELICAR P
Citation: V. Lassmannvague et al., AUTOIMMUNITY AND INTRAPERITONEAL INSULIN-TREATMENT BY PROGRAMMABLE PUMPS - LACK OF RELATIONSHIP, Diabetes care, 21(11), 1998, pp. 2041-2043
Authors:
VAGUE P
DUFAYET D
LAMOTTE MF
MOUCHOT C
RACCAH D
Citation: P. Vague et al., GENETIC-FACTORS, NA K ATPASE ACTIVITY, AND DIABETIC NEUROPATHY/, La Semaine des hopitaux de Paris, 74(23-26), 1998, pp. 959-965
Authors:
ERKINTALO M
BENDAHAN D
MATTEI JP
FABRGUETTES C
VAGUE P
COZZONE PJ
Citation: M. Erkintalo et al., REDUCED METABOLIC EFFICIENCY OF SKELETAL-MUSCLE ENERGETICS IN HYPERTHYROID PATIENTS EVIDENCED QUANTITATIVELY BY IN-VIVO P-31 MAGNETIC-RESONANCE SPECTROSCOPY, Metabolism, clinical and experimental, 47(7), 1998, pp. 769-776
Authors:
GERBI A
MAIXENT JM
BARBEY O
JAMME I
PIERLOVISI M
COSTE T
PIERONI G
NOUVELOT A
VAGUE P
RACCAH D
Citation: A. Gerbi et al., ALTERATIONS OF NA,K-ATPASE ISOENZYMES IN THE RAT DIABETIC NEUROPATHY - PROTECTIVE EFFECT OF DIETARY SUPPLEMENTATION WITH N-3 FATTY-ACIDS, Journal of neurochemistry, 71(2), 1998, pp. 732-740
Authors:
DELATOUR DD
RACCAH D
JANNOT MF
COSTE T
ROUGERIE C
VAGUE P
Citation: Dd. Delatour et al., ERYTHROCYTE NA K ATPASE ACTIVITY AND DIABETES - RELATIONSHIP WITH C-PEPTIDE LEVEL/, Diabetologia, 41(9), 1998, pp. 1080-1084
Authors:
PAQUISFLUCKLINGER V
VIALETTES B
VAGUE P
CANIVET B
HIERONIMUS S
OLIVER C
PELLISSIER JF
SAUNIERES A
DESNUELLE C
Citation: V. Paquisflucklinger et al., IMPORTANCE OF SEARCHING FOR MTDNA DEFECTS IN PATIENTS WITH DIABETES AND HEARING DEFICIT, Diabetologia, 41(6), 1998, pp. 740-741
Authors:
LASSMANNVAGUE V
ALESSIS C
VAGUE P
BELICAR P
Citation: V. Lassmannvague et al., ARE INSULIN KINETICS REPRODUCIBLE AFTER LONG-TERM INTRAPERITONEAL INSULIN-TREATMENT IN PATIENTS WITH TYPE-1 DIABETES, Diabetologia, 41, 1998, pp. 876-876
Authors:
LASSMANNVAGUE V
JANANDDELENNE B
SAVIN B
HABIB G
BORY M
VAGUE P
Citation: V. Lassmannvague et al., A STRATEGY OF SYSTEMATIC SCREENING FOR SILENT-MYOCARDIAL-ISCHEMIA (SMI) PROVED BY CORONAROGRAPHY - RESULTS IN 203 PATIENTS WITH DIABETES, Diabetes, 47, 1998, pp. 270-270
Authors:
LASSMANNVAGUE V
ALESSIS C
VAGUE P
BELICAR P
Citation: V. Lassmannvague et al., ARE INSULIN KINETICS REPRODUCIBLE AFTER LONG-TERM INTRAPERITONEAL (IP) INSULIN-TREATMENT IN PATIENTS WITH TYPE-I DIABETES, Diabetes, 47, 1998, pp. 385-385
Authors:
LASSMANNVAGUE V
GUERCI B
HANAIREBROUTIN H
PINGET M
RENARD E
SELAM JL
VAGUE P
Citation: V. Lassmannvague et al., USE OF IMPLANTABLE INSULIN PUMPS - THE EV ADIAC POSITION, Diabetes & metabolism, 23(3), 1997, pp. 234-250
Authors:
BERNARD MC
RENUCCI JF
TOSELLO N
GOUVERNET J
VAGUE P
Citation: Mc. Bernard et al., NUTRITION IN PATIENTS TREATED WITH LIPID- LOWERING DRUGS, La Presse medicale, 26(13), 1997, pp. 598-602
Authors:
SCAVINI M
GALLI L
REICH S
EATON RP
CHARLES MA
DUNN FL
MICOSSI P
TORRI M
PETRELLA G
GALIMBERTI G
CRISTALLO M
VAI S
POZZA G
OLSEN C
TURNER D
NOLLEMAN C
LAVINTOMPKINS J
SELAM JL
HAARDT MJ
DORANGE C
JEANDIDIER N
ORTEGA F
BOIVIN S
NATHAN D
LARKIN M
MCKITRICK C
SCHWARZ S
FISHER J
KIPNES S
WALZ B
VAGUE P
REEVES ML
GOUDNER M
THOMSON GP
JAFFIOL C
RENARD E
LAUTON D
JACQUESAPOSTOL D
BRINGER J
TAUBER JP
HANAIREBROUTIN H
REESJONES R
ADOLFF S
BAYS HA
PFEIFER M
CLARKE D
IRSIGLER K
FEINBOCH C
HUTTER R
MENDEL H
DIGLAS J
Citation: M. Scavini et al., CATHETER SURVIVAL DURING LONG-TERM INSULIN THERAPY WITH AN IMPLANTED PROGRAMMABLE PUMP, Diabetes care, 20(4), 1997, pp. 610-613
Authors:
RACCAH D
FABREGUETTES C
AZULAY JP
VAGUE P
Citation: D. Raccah et al., ERYTHROCYTE NA-K+-ATPASE ACTIVITY, METABOLIC CONTROL, AND NEUROPATHY IN IDDM PATIENTS (VOL 19, PG 564, 1996)(), Diabetes care, 20(2), 1997, pp. 236-236
Authors:
FONTBONNE A
CHARLES MA
JUHANVAGUE I
BARD JM
ANDRE P
ISNARD F
COHEN JM
GRANDMOTTET P
VAGUE P
SAFAR ME
ESCHWEGE E
Citation: A. Fontbonne et al., THE EFFECT OF METFORMIN ON THE METABOLIC ABNORMALITIES ASSOCIATED WITH UPPER-BODY FAT DISTRIBUTION (VOL 19, 920, 1996), Diabetes care, 20(1), 1997, pp. 119-119
Authors:
VIBERTI G
SLAMA G
POZZA G
CZYZYK A
BILOUS RW
GRIES A
KEEN H
FULLER JH
MENZINGER G
DIMARIO U
NAVALESI R
BRUNETTI P
PIRAS G
MUGGEO M
TIENGO A
FEDERLE D
DEFERRARI D
NOACCO C
CHARBONNEL B
SELAM J
VAGUE P
DROUIN P
HALIMI S
GRESZCZAK W
CZEKALSKI S
SIERADZKI J
FOVENYI J
KERENYI Z
KAMMERER L
SAUDEK F
VONDRA K
ANDEL M
DRORAKOVA L
HEPP KD
KOSCHINSKY T
LEHNERT H
STANDL E
MARSHALL S
BOULTON A
MACCUISH A
HYER S
Citation: G. Viberti et al., EARLY CLOSURE OF EUROPEAN PIMAGEDINE TRIAL, Lancet, 350(9072), 1997, pp. 214-215
Authors:
VAGUE P
JUHANVAGUE I
Citation: P. Vague et I. Juhanvague, FIBRINOGEN, FIBRINOLYSIS AND DIABETES-MELLITUS - A COMMENT, Diabetologia, 40(6), 1997, pp. 738-740
Authors:
GERBI A
BARBEY O
RACCAH D
COSTE T
JAMME I
NOUVELOT A
OUAFIK L
LEVY S
VAGUE P
MAIXENT JM
Citation: A. Gerbi et al., ALTERATION OF NA,K-ATPASE ISOENZYMES IN DIABETIC CARDIOMYOPATHY - EFFECT OF DIETARY SUPPLEMENTATION WITH FISH-OIL (N-3 FATTY-ACIDS) IN RATS, Diabetologia, 40(5), 1997, pp. 496-505
Authors:
VAGUE P
DUFAYET D
COSTE T
MORISCOT C
JANNOT MF
RACCAH D
Citation: P. Vague et al., ASSOCIATION OF DIABETIC NEUROPATHY WITH NA K ATPASE GENE POLYMORPHISM/, Diabetologia, 40(5), 1997, pp. 506-511
Authors:
GERBI A
MAIXENT JM
BARBEY O
COSTE T
PIERLOVISI M
NOUVELOT A
VAGUE P
RACCAH D
Citation: A. Gerbi et al., BENEFICIAL EFFECT OF DIETARY OMEGA-3-FATTY-ACIDS ON NA,K-ATPASE AND NERVE FUNCTION IN DIABETIC NEUROPATHY, Diabetologia, 40, 1997, pp. 118-118
Authors:
JANANDDELENNE B
CHAGNAUD C
ALESSI MC
JUHANVAGUE I
VAGUE P
Citation: B. Jananddelenne et al., VISCERAL FAT IS ASSOCIATED WITH INCREASED PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS IN WOMEN, Diabetologia, 40, 1997, pp. 1024-1024
Authors:
BELICAR P
LASSMANNVAGUE V
ALESSIS C
VAGUE P
Citation: P. Belicar et al., WHAT ABOUT ANTI INSULIN IMMUNOGENICITY ON A LONG-TERM IN DIABETIC-PATIENTS TREATED WITH IMPLANTABLE INSULIN PUMP, Diabetologia, 40, 1997, pp. 1324-1324